14:42 – 14:50 Development and regulatory approval of zopapogene imadenovec-drba, the first FDA-approved treatment for adults with recurrent respiratory papillomatosis – Clint Allen (GUEST, Bethesda)

  • TUESDAY AUGUST 25

    Session 6 – Laryngology & Pediatrics & Genetics

    Date: 25 Aug 2026Time: 13:30 - 15:30
    Chairs: Sharon L Cushing (MEMBER, Toronto), Anne Schilder (MEMBER, Londen)
Home › 14:42 - 14:50 Development and regulatory approval of zopapogene imadenovec-drba, the first FDA-approved treatment for adults with recurrent respiratory papillomatosis - Clint Allen (GUEST, Bethesda)
Website and marketing